Measuring risk before tricuspid valve treatment
Part of Heart & circulation clinical trials.
This study looks at a new way to measure risk in people who are getting treatment for a leaky tricuspid valve. The goal is to help doctors better predict who might benefit from the procedure, which is done to reduce heart failure symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe or torrential tricuspid regurgitation (a leaky heart valve on the right side).
- You are already scheduled for a procedure to repair or replace that valve (like a clip or a replacement) to help with heart failure symptoms.
- You must be 18 years of age or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This study tracks people with a leaking tricuspid valve and weakened heart pumping to see how a minimally invasive repair procedure affects their health over time. It aims to improve treatment for those with heart failure.
This trial tests a new, less-invasive device called 'Pivot Extend' for people with a severe leaky tricuspid valve (tricuspid regurgitation) who still have symptoms despite taking medicines. The goal is to see if the device can safely help reduce the leak and improve symptoms.
This study tests a new device to help people with severe tricuspid regurgitation (leaky heart valve) who are at higher risk from surgery. It aims to see if the device can reduce the leak and improve symptoms.
This study tests a new, catheter-based procedure to treat moderate-to-severe leaking of the tricuspid valve (a heart valve on the right side). It’s for people who are high surgical risk and might benefit from replacing the valve without open-heart surgery.
This study follows adults with a severely leaky tricuspid heart valve who still have symptoms despite medication. It looks at outcomes after a procedure called TriClip, which helps reduce valve leakage.
Hear when a new Tricuspid Regurgitation (TR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.